Search

Jazz Pharmaceuticals PLC

Fermé

SecteurSoins de santé

254.35 0.04

Résumé

Variation du prix de l'action

24h

Actuel

Min

253.24

Max

255.36

Chiffres clés

By Trading Economics

Revenu

-100M

193M

Ventes

139M

1.2B

P/E

Moyenne du Secteur

16.77

57.371

BPA

4.89

Marge bénéficiaire

15.956

Employés

2,890

EBITDA

-126M

418M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+12.55% upside

Dividendes

By Acuity

Prochains Résultats

4 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

238M

16B

Ouverture précédente

254.31

Clôture précédente

254.35

Sentiment de l'Actualité

By Acuity

17%

83%

29 / 340 Classement par Healthcare

Jazz Pharmaceuticals PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 août 2026, 00:02 UTC

Jazz Pharmaceuticals PLC shares are lower in after-market hours, continuing a decline since Friday's close, despite broader gains in major U.S. stocks.

21 août 2026, 20:06 UTC

Jazz Pharmaceuticals PLC shares are higher during Friday's session, reflecting strong upward momentum since Thursday's close, despite a recent pullback from session highs.

20 août 2026, 19:56 UTC

Jazz Pharmaceuticals PLC shares are lower amid a broader market decline following disappointing sales growth and guidance from Walmart. They remain below their 20-day moving average.

19 août 2026, 22:36 UTC

Jazz Pharmaceuticals PLC shares are lower in after-market hours, continuing a decline from regular trading, despite a broader recovery in equities.

18 août 2026, 20:03 UTC

Jazz Pharmaceuticals shares are trading higher, reflecting strength in the pharmaceuticals sector, despite a slight pullback from earlier session gains.

17 août 2026, 23:31 UTC

Jazz Pharmaceuticals PLC shares declined during after-market hours, reflecting broader market pressures from rising crude oil prices amid escalating U.S.-Iran tensions.

12 août 2026, 19:46 UTC

News

Jazz Pharmaceuticals shares are higher after Q2 revenue rose 16% to $1.21 billion, exceeding expectations. The company raised its full-year guidance to $4.68 billion.

11 août 2026, 22:46 UTC

Jazz Pharmaceuticals PLC shares advanced in after-market trading, diverging from broader market trends that closed lower amid rising crude oil prices.

10 août 2026, 19:56 UTC

Event
Social Media
News

Jazz Pharmaceuticals PLC to acquire Actio Biosciences for $820 million, enhancing its rare epilepsy portfolio. Shares are higher despite earlier session pullback.

7 août 2026, 19:36 UTC

Jazz Pharmaceuticals shares are higher today, reflecting broader market gains amid expectations the Federal Reserve may pause interest rate hikes.

6 août 2026, 19:21 UTC

Jazz Pharmaceuticals PLC shares are lower today, despite earlier gains. Mixed economic signals contribute to cautious sentiment ahead of the non-farm payrolls report.

5 août 2026, 19:36 UTC

News

Shares of Jazz Pharmaceuticals PLC are lower today, despite earlier gains. The company raised its full-year revenue guidance, driven by strong performance from Xywav.

4 août 2026, 20:04 UTC

Social Media
News

Jazz Pharmaceuticals PLC shares rise as analysts upgrade price targets, following strong Q2 results that beat revenue estimates and boosted 2026 sales guidance.

3 août 2026, 23:02 UTC

News

Jazz Pharmaceuticals reported Q2 revenues of $1.208 billion, exceeding expectations. Shares advanced in after-market trading following the raised full-year guidance.

31 juil. 2026, 23:21 UTC

Jazz Pharmaceuticals PLC shares are lower in after-market trading, pulled back from earlier session highs amid broader market declines, particularly in major tech stocks.

30 juil. 2026, 19:59 UTC

Jazz Pharmaceuticals shares are higher, reflecting broader market recovery amid significant gains in the technology sector. The stock is near the upper end of its one-month range.

29 juil. 2026, 18:26 UTC

Jazz Pharmaceuticals PLC is trading higher during Wednesday's session, with fluctuations within a routine range and positioned above its 20-day moving average.

28 juil. 2026, 23:46 UTC

Jazz Pharmaceuticals PLC shares are higher in after-market trading, recovering from an early low and remaining above the 20-day moving average.

27 juil. 2026, 19:37 UTC

Social Media

Jazz Pharmaceuticals PLC is trading higher, recently reaching a new 52-week high amid increased investor interest and significant average volume exceeding $50 million.

24 juil. 2026, 20:07 UTC

Jazz Pharmaceuticals PLC shares are lower today amid broader market dynamics influenced by recent oil price volatility, despite remaining above its 20-day moving average.

21 juil. 2026, 19:02 UTC

Jazz Pharmaceuticals PLC is trading higher today, despite no specific news. Positive sentiment in the semiconductor sector may be contributing to overall investor optimism.

20 juil. 2026, 23:36 UTC

News

Jazz Pharmaceuticals PLC will report second-quarter results on August 3, contributing to positive investor sentiment as shares trade higher after market hours.

Comparaison

Variation de prix

Jazz Pharmaceuticals PLC prévision

Objectif de Prix

By TipRanks

12.55% hausse

Prévisions sur 12 Mois

Moyen 286.19 USD  12.55%

Haut 315 USD

Bas 229 USD

Basé sur 17 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

17 ratings

16

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

29 / 340Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

help-icon Live chat